IR@PKUHSC  > 北京大学第二临床医学院  > 心血管内科
学科主题临床医学
Efficacy and safety of Firebird sirolimus-eluting stent in treatment of complex coronary lesions in Chinese patients: one-year clinical and eight-month angiographic outcomes froth the FIREMAN registry
Li Yan1; Li Cheng-xiang1; Wang Hai-chang1; Xu Bo2,3; Fang Wei-yi4; Ge Jun-bo5; Wang Wei-min6; Qiao Shu-bin2,3; Chen, Jack-P7,8; Shen Wen-kuang9; Jiang Hong10; Cong Hong-liang11; Pu Xiao-qun12; Qin Yong-wen13; Jin Hui-gen14; Cao Yu15; Huang He16; FIREMAN Investigators
关键词coronary artery disease sirolimus-eluting sent off-label use clinical outcomes
刊名CHINESE MEDICAL JOURNAL
2011-03-20
DOI10.3760/cma.j.issn.0366-6999.2011.06.004
124期:6页:817-824
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
研究领域[WOS]General & Internal Medicine
关键词[WOS]BARE-METAL STENTS ; OFF-LABEL USE ; ARTERY-DISEASE ; THROMBOSIS ; INTERVENTION ; IMPLANTATION ; TRIALS
英文摘要

Background Off-label application of drug-eluting stents (DES) during percutaneous coronary intervention (PCI) was not uncommon in daily practice, however DES in treating Chinese patients with complex lesion subset was under-investigated. The primary,objective of the FIREMAN registry was,to evaluate the long term efficacy and safety of the Firebird sirolimus-eluting stent (SES) in treating patients with complex coronary lesions. Here we report the mid-term of one-year clinical outcomes and eight-month angiographic follow-up results of FIREMAN registry.

Methods The FIREMAN registry was a prospective multi-center registry, which included 1029 consecutive patients undergoing PCI with Firebird SES implantation between September 2006 and July 2007 in 45 centers in China. The clinical follow-up was designed to be performed at 1, 6, 12, 18, 24, 30 and 36 months post index procedure, and non-mandatory angiographic follow-up at 8 months was planned. One hundred percent site monitoring was conducted.

Results Long lesions (59.2%), multi-vessel disease (50.4%), and small vessel disease (31.6%) were mostly found in angiography. Major adverse cardiac events (MACE) occurred in 51 (5.1%) patients at 1 year clinical follow-up, including cardiac mortality in 6 (0.6%), non-fatal myocardial infarction in 11(1.1%), and target lesion revascularization in 36 (3.5%) of the patients. Definite and probable stent thrombosis (ST) by Academic Research Consortium (ARC) definition occurred in 12 (1.36%) patients at one-year clinical follow-up. The 8-month binary restenosis rate was 5.7% in-segment and 4.3% in-stent, respectively. Late lumen loss was (0.21 +/- 0.40) mm in-segment and (0.23 +/- 0.36) mm in-stent, respectively. Furthermore, Cox regression analysis revealed that diabetes, small vessel diameter, and chronic total occlusion were independent predictors of ST.

Conclusions The results showed that the Firebird SES was effective and safe in treating Chinese patients with complex coronary lesions and occurrence of ST rate at one-year clinical follow-up was acceptable, however further long-term follow-up was still necessary. (NCT00552656) Chin Med J 2011;124(6):817-824

语种英语
WOS记录号WOS:000289040900004
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63356
专题北京大学第二临床医学院_心血管内科
作者单位1.St Josephs Heart & Vasc Inst, Atlanta, GA USA
2.Northside Hosp, Atlanta, GA USA
3.Fourth Mil Med Univ, Dept Cardiol, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China
4.Chinese Acad Med Sci, Dept Cardiol, FuWai Hosp, Beijing 100037, Peoples R China
5.Peking Union Med Coll, Beijing 100037, Peoples R China
6.Shanghai Jiao Tong Univ, Sch Med, Dept Cardiol, Shanghai Chest Hosp, Shanghai 200030, Peoples R China
7.Shanghai Fudan Univ, Sch Med, Dept Cardiol, Shanghai Zhongshan Hosp, Shanghai 200032, Peoples R China
8.Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100044, Peoples R China
9.Mayo Clin, Rochester, MN 55905 USA
10.Wuhan Univ, Dept Cardiol, Peoples Hopsital, Wuhan 430060, Hubei, Peoples R China
11.Tianjin Chest Hosp, Dept Cardiol, Tianjin 300051, Peoples R China
12.Cent S Univ, Dept Cardiol, Xiangya Affiliated Hosp 1, Changsha 410008, Hunan, Peoples R China
13.Second Mil Med Univ, Changhai Hosp, Dept Cardiol, Shanghai 200433, Peoples R China
14.Putuo Dist Cent Hosp, Shanghai 200060, Peoples R China
15.Cent S Univ, Xiangya Affiliated Hosp 3, Dept Cardiology, Changha 410008, Hunan, Peoples R China
16.Xiangtan Cent Hosp, Xiangtan 411100, Hunan, Peoples R China
推荐引用方式
GB/T 7714
Li Yan,Li Cheng-xiang,Wang Hai-chang,et al. Efficacy and safety of Firebird sirolimus-eluting stent in treatment of complex coronary lesions in Chinese patients: one-year clinical and eight-month angiographic outcomes froth the FIREMAN registry[J]. CHINESE MEDICAL JOURNAL,2011,124(6):817-824.
APA Li Yan.,Li Cheng-xiang.,Wang Hai-chang.,Xu Bo.,Fang Wei-yi.,...&FIREMAN Investigators.(2011).Efficacy and safety of Firebird sirolimus-eluting stent in treatment of complex coronary lesions in Chinese patients: one-year clinical and eight-month angiographic outcomes froth the FIREMAN registry.CHINESE MEDICAL JOURNAL,124(6),817-824.
MLA Li Yan,et al."Efficacy and safety of Firebird sirolimus-eluting stent in treatment of complex coronary lesions in Chinese patients: one-year clinical and eight-month angiographic outcomes froth the FIREMAN registry".CHINESE MEDICAL JOURNAL 124.6(2011):817-824.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li Yan]的文章
[Li Cheng-xiang]的文章
[Wang Hai-chang]的文章
百度学术
百度学术中相似的文章
[Li Yan]的文章
[Li Cheng-xiang]的文章
[Wang Hai-chang]的文章
必应学术
必应学术中相似的文章
[Li Yan]的文章
[Li Cheng-xiang]的文章
[Wang Hai-chang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。